The American Journal of Medicine
Volume 86, Issue 4 , Pages 385-390 , April 1989

Familial Occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus

Received 15 June 1988 ,Accepted 25 January 1989.

References 

  1. Leonhardt T. Family studies in systemic lupus erythematosus. Acta Med Scand. 1964;176(suppl 416):1–156
  2. Estes D, Christian CL. The natural history of systemic lupus erythematosus by prospective analysis. Medicine (Baltimore). 1971;50:85–95
  3. Block SR, Winfield JB, Lockshin MD, D'Anelo WA, Christian CL. Studies of twins with systemic lupus erythematosus: a review of the literature and presentation of 12 additional sets. Am J Med. 1975;59:533–552
  4. Dehoratius RJ, Messner RP. Lymphocytotoxic antibodies in family members of patients with SLE. J Clin Invest. 1975;55:1254–1258
  5. Arnett FC, Shulman LE. Studies in familial systemic lupus erythematosus. Medicine (Baltimore). 1976;55:313–322
  6. Block SR, Lockshin MD, Winfield JB, et al. Immunologic observations on 9 sets of twins either concordant or discordant for systemic lupus erythematosus. Arthritis Rheum. 1976;19:545–554
  7. Cleland LG, Bell DA, Williams M, Sauräno BC. Familial lupus: family studies of HLA and serologic findings. Arthritis Rheum. 1978;21:183–191
  8. Buckman KJ, Moore SK, Ebbin AJ, Cox MB, Dubois EL. Familial systemic lupus erythematosus. Arch Intern Med. 1978;138:1674–1676
  9. Russell AS. Genetic factors in systemic lupus erythematosus. Semin Arthritis Rheum. 1981;10:255–263
  10. Reveille JD, Bias WB, Winkelstein JA, Provost TT, Dorsch CA, Arnett FC. Familial systemic lupus erythematosus: immunogenetic studies in eight families. Medicine (Baltimore). 1983;62:21–35
  11. Smith HR, Steinberg AD. Autoimmunity—a perspective. Annu Rev Immunol. 1983;1:175–210
  12. Agnello V, debracco MME, Kunkel HG. Hereditary C2 deficiency with some manifestations of systemic lupus erythematosus. J Immunol. 1972;108:837–840
  13. Agnello V. Complement deficiency states. Medicine (Baltimore). 1978;57:1–24
  14. Tappeiner G. Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement. J Am Acad Dermatol. 1982;7:66–79
  15. Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL, Mann DL. B-lymphocyte alloantigens associated with systemic lupus erythematosus. N Engl J Med. 1978;299:515–518
  16. Gibofsky A, Wichester RJ, Patarroyo M, Fotino M, Kunkel HG. Disease associations of the 1a-like human alloantigens: contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus. J Exp Med. 1978;148:1728–1732
  17. Cleland LG, Bell DA, Williams M. Familial lupus: family studies of HLA and serologic findings. Arthritis Rheum. 1978;21:183–191
  18. Ahearn JM, Provost TT, Dorsch CA, Stevens MB, Arnett FC. The interrelationship of HLA-DR, MB and MT phenotypes, autoantibody expression and clinical features in systemic lupus erythematosus (SLE). Arthritis Rheum. 1982;25:1031–1040
  19. Schur PH, Meyer I, Gorovoy M, Carpenter DB. Association between systemic lupus erythematosus and the major histocompatibility complex: clinical and immunological consideration. Clin Immunol Immunopathol. 1982;24:263–275
  20. Black CM, Welsh KI, Fielder A, Hughes GRV, Batchelor JR. HLA antigens and Bf allotypes in SLE: evidence for the association being with specific haplotypes. Tissue Antigens. 1982;19:115–120
  21. Reinertsen JL, Klippel JH, Johnson AH, Steinberg AD, Decker JL. Family studies of B lymphocyte alloantigens in systemic lupus erythematosus. J Rheumatol. 1982;9:253–262
  22. Alarif LI, Ruppert GB, Wilson RJ, Barth WF. HLA-DR antigens in blacks with rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol. 1983;10:297–300
  23. Howard PF, Hochberg MC, Bias WB, Arnett FC, McLean RT. Relationship between C4 nuli genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. Am J Med. 1986;81:187–193
  24. Kemp ME, Atkinson JP, Skanes VM, Levine RP, Chaplin DD. Deletion of C4A genes in patients with systemic lupus erythematosus. Arthritis Rheum. 1987;30:1015–1022
  25. Theofilopoulos AN, Dixon FJ. Murine models of systemic lupus erythematosus. Adv Immunol. 1985;37:269–390
  26. Steinberg AD, Smolen JS, Sakane T, et al. Immune regulatory abnormalities in systemic lupus erythematosus. In:  Cummings NB,  Michael AF,  Wilson CB editor. Immune mechanisms in renal desease. New York: Plenum Publishing Corporation; 1982;p. 529–548
  27. Rosenthal CJ, Franklin EC. Depression of cellular-mediated immunity in systemic lupus erythematosus. Arthritis Rheum. 1975;18:207–217
  28. Sakane T, Steinberg AD, Green I. Failure of autologous mixed lymphocyte reactions between T and non-T cells in patients with systemic lupus erythematosus. In: 4th ed.. Proc Natl Acad Sci USA. 75:1978;p. 3464–3468
  29. Sakane T, Steinberg AD, Green I. Studies of immune functions of patients with systemic lupus erythematosus. I. Dysfunctions of suppressor T-cell activity related to impaired generation of, rather than response to, suppressor cells. Arthritis Rheum. 1978;21:657–664
  30. Sakane T, Steinberg AD, Reeves JP, Green I. Studies of immune functions of patients with systemic lupus erythematosus: T-cell subsets and antibodies to T-cell subsets. J Clin Invest. 1979;64:1260–1269
  31. Sakane T, Steinberg AD, Green I. Studies of immune functions of patients with systemic lupus erythematosus. V. T cell suppressor function and autologous mixed lymphocyte reaction during active and inactive phases of disease. Arthritis Rheum. 1980;23:225–231
  32. Blaese RM, Grayson J, Steinberg AD. Increased immunoglobulin-secreting cells in the blood of patients with active systemic lupus erythematosus. Am J Med. 1980;69:345–350
  33. Honda M, Sakane T, Steinberg AD, et al. Studies of immune functions of patiens with systemic lupus erythematosus: antibodies to desialized, rather than intact, T cells preferentially bind to and eliminate suppressor effector T cells. J Clin Invest. 1982;69:940–949
  34. Sakane T, Kotani H, Takada S, Murakawa Y, Ueda Y. A defect in the suppressor circuits among OKT4+ cell populations in patients with systemic lupus erythematosus occurs independently of a defect in the OKT8+ suppressor T cell function. J Immunol. 1983;131:753–761
  35. Murakawa Y, Takada S, Ueda Y, Suzuki N, Hoshino T, Sakane T. Characterization of T Lymphocyte subpopulations responsible for deficient interleukin-2 actviity in patients with systemic lupus erythematosus. J Immunol. 1985;134:187–195
  36. Takada S, Ueda Y, Suzuki N, et al. Abnormalities in autologous mixed lymphocyte reaction-activated immunologic processes in systemic lupus erythematosus and their possible correction by interleukin-2. Eur J Immunol. 1985;15:262–267
  37. Huang Y-P, Miescher PA, Zubler RH. The interleukin-2 secreting defect in vitro in systemic lupus erythematosus is reversible in rested cultured T cells. J Immunol. 1986;137:3515–3520
  38. Sakane T, Takada S, Suzuki N, Tsuchida T, Murakawa Y, Ueda Y. Deficiencies in suppressor T cell activity seen in patients with active systemic lupus erythematosus are due to the dilution of normally functioning suppressor T cells by the nonsuppressor T cells. J Immunol. 1986;137:3809–3813
  39. Sakane T, Suzuki N, Takada S, et al. B cell hyperactivity and its relation to distinct clinical features and the degree of disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1988;31:80–87
  40. Murakawa Y, Sakane T. Deficient phytohemagglutinin-induced interleukin-2 activity in patients with inactive systemic lupus erythematosus is correctable by the addition to phorbol myristate acetate. Arthritis Rheum. 1988;31:826–833
  41. Weksler ME, Moody CE, Kozak RW. The autologous mixed-lymphocyte reaction. Adv Immunol. 1981;31:271–312
  42. Smith JB, Talal N. Significance of self-recognition and interleukin-2 for immunoregulation, autoimmunity and cancer. Scand J Immunol. 1982;16:269–278
  43. Miller KB, Schwarz RS. Familial abnormalities of suppressor-cell function in systemic lupus erythematosus. N Engl J Med. 1979;301:803–809
  44. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271–1277
  45. Alcocer-Varela J, Alarćon-Segovia D. Decreased production of and response to interleukin-2 by cultured lymphocytes from patients with systemic lupus erythematosus. J Clin Invest. 1982;69:1388–1392
  46. Farrar JJ, Mizel SB, Fuller-Farrar J, Farrar WL, Hilfiker ML. Macrophage-independent activation of helper T cells. I. Production of interleukin-2. J Immunol. 1980;125:793–798
  47. Suzuki N, Sakane T, Ueda Y, Murakawa Y, Tsunematsu T. Implications for the role of cognate interactions in in vitro human B cell activation of Staphylococcus aureus Cowan I and pokeweed mitogen. J Clin Invest. 1986;77:294–300
  48. Suzuki N, Ueda Y, Sakane T. Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density. J Clin Invest. 1988;81:261–269
  49. Gronowicz E, Coutinho A, Melchers SF. A plaque assay for all cells secreting Ig of a given type or class. Eur J Immunol. 1976;6:588–590
  50. Kitagawa J, Iho S, Yokochi T, Hoshino T. Detection of antibodies to the Epstein-Barr virus nuclear antigens in the sera from patients with systemic lupus erythematosus. Immunol Letters. 1988;17:248–252
  51. Steinberg AD, Baron S, Talal N. The pathogenesis of autoimmunity in New Zealand mice. I. Induction of anti-nucleic acid antibodies by polyinosinic polycytidylic acid. In: 4th ed.. Proc Natl Acad Sci USA. 63:1969;p. 1102–1107
  52. Steinberg AD, Huston DP, Taurog JD, Cowdery JS, Raveche ES. The cellular and genetic basis of murine lupus. Immunol Rev. 1981;55:121–154

☆ This work was supported in part by a 1988 grant-in-aid for scientific research (project number 63480191) from the Ministry of Education, Science, and Culture of Japan, and by a 1988 research grant from the Autoimmune Disease Research Committee of Japan, Ministry of Welfare, Tokyo, Japan.

PII: 0002-9343(89)90334-3

doi: 10.1016/0002-9343(89)90334-3

The American Journal of Medicine
Volume 86, Issue 4 , Pages 385-390 , April 1989

Article Tools